tablets in pink background

POLL: Does having an anti-viral COVID-19 drug available make you less likely to get vaccinated in the future?

In a potential drug development game-changer, a major advance in combating Covid-19 has shown great promise in clinical trials. Per the Associated Press, “Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. If cleared, the drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorized in the U.S. require an IV or injection.” Normally, treatments that transition from needle vaccinations to pill form gain wider adoption by the public, not to mention greater profits for the company that develops it. https://bit.ly/3mjbsqy


Tiny microscopic hunters could be a crystal ball for climate change.
DURHAM, N.C. — It’s hard to know what climate change will mean …
Scientists make breakthrough in understanding how penicillin works
The mechanism which allows β-lactam antibiotics, including penicillin, to kill MRSA has …
Trigonopterus corona, the new species of tiny beetle named after the coronavirus.
Many curious animals can be found on the Indonesian Island of Sulawesi …
University of Surrey maps path to carbon neutrality
Ahead of COP26 in Glasgow, the University of Surrey has published a …

Processing…
Success! You're on the list.

Leave a Reply

%d bloggers like this: